The Enterprise Value as of December 2024 (TTM) for Galera Therapeutics, Inc. (GRTX) is -6768842.00

According to Galera Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -6768842.00. This represents a change of -109.58% compared to the average of 70.62M of the last 4 quarters.

Galera Therapeutics, Inc. (GRTX) Historical Enterprise Value (quarterly & annually)

How has GRTX Enterprise Value performed in the past?

The mean historical Enterprise Value of Galera Therapeutics, Inc. over the last ten years is 155.25M. The current -6768842.00 Enterprise Value has changed -535.99% with respect to the historical average. Over the past ten years (40 quarters), GRTX's Enterprise Value was at its highest in in the March 2019 quarter at 313.86M. The Enterprise Value was at its lowest in in the September 2023 quarter at -15129810.60.

Galera Therapeutics, Inc. (GRTX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Galera Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Galera Therapeutics, Inc. (GRTX) Average Enterprise Value

How has GRTX Enterprise Value performed in the past?

The current Enterprise Value of Galera Therapeutics, Inc. (GRTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Galera Therapeutics, Inc. (GRTX) Enterprise Value vs. Peers

How is GRTX’s Enterprise Value compared to its peers?

Galera Therapeutics, Inc.’s Enterprise Value is less than Mereo BioPharma Group plc (445.16M), less than Terns Pharmaceuticals, Inc. (234.86M), less than PDS Biotechnology Corporation (37.39M), less than Inozyme Pharma, Inc. (215.58M), greater than HOOKIPA Pharma Inc. (-37325309.00), less than X4 Pharmaceuticals, Inc. (79.21M), less than Acumen Pharmaceuticals, Inc. (103.15M), less than Day One Biopharmaceuticals, Inc. (859.59M), less than Amylyx Pharmaceuticals, Inc. (209.72M),

Build a custom stock screener for Galera Therapeutics, Inc. (GRTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Galera Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Galera Therapeutics, Inc. (GRTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Galera Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.